Abstract
The current off-patent state of tacrolimus (FK506) has opened the hunting season for new generic pharmaceutical formulations of this immunosuppressant. This fact has boosted the scientific and industrial research on tacrolimus for the last 5 years in order to improve its production. The fast discovery of tacrolimus producer strains has generated a huge number of producers, which presents the biosynthetic cluster of FK506 as a high promiscuous genetic region. For the first time, the current state-of-the-art on the tacrolimus biosynthesis, production improvements and drug purification is reviewed. On one hand, all the genes involved in the tacrolimus biosynthesis, in addition to the traditional PKS/NRPS, as well as their regulation are analysed. On the other hand, tacrolimus direct and indirect precursors are reviewed as a straight manner to improve the final yield, which is a current trend in the field. Twenty years of industrial and scientific improvements on tacrolimus production are summarised, whereas future trends are also drafted.
Similar content being viewed by others
References
Altschuler EL, Calude AS, Meade A, Pagel M (2013) Linguistic evidence supports date for Homeric epics. BioEssays 35:417–420
Andexer JN, Kendrew SG, Nur-e-Alam M, Lazos O, Foster TA, Zimmermann A-S, Warneck TD, Suthar D, Coates NJ, Koehn FE, Skotnicki JS, Carter GT, Gregory MA, Martin CJ, Moss SJ, Leadlay PF, Wilkinson B (2011) Biosynthesis of the immunosuppressants FK506, FK520, and rapamycin involves a previously undescribed family of enzymes acting on chorismate. Proc Natl Acad Sci U S A 108:4776–4781
Barreiro C, Martín JF, García-Estrada C (2012a) Proteomics shows new faces for the old penicillin producer Penicillium chrysogenum. J Biomed Biotechnol 2012:1–15
Barreiro C, Prieto C, Sola-Landa A, Solera E, Martínez-Castro M, Pérez-Redondo R, García-Estrada C, Aparicio JF, Fernández-Martínez LT, Santos-Aberturas J, Salehi-Najafabadi Z, Rodríguez-García A, Tauch A, Martín JF (2012b) Draft genome of Streptomyces tsukubaensis NRRL 18488, the producer of the clinically important immunosuppressant tacrolimus (FK506). J Bacteriol 194:3756–3757
Bibb MJ (2005) Regulation of secondary metabolism in streptomycetes. Curr Opin Microbiol 8:208–215
Bibb M, Hesketh A (2009) Chapter 4. Analyzing the regulation of antibiotic production in streptomycetes. Methods Enzymol 458:93–116
Borel JF, Kis ZL (1991) The discovery and development of cyclosporine (Sandimmune). Transplant Proc 23:1867–1874
Burget U, Zundel G (1986) Lysine–phosphate hydrogen bonds and hydrogen-bonded chains with large proton polarizability in polylysine–phosphate systems: IR investigations. J Mol Struct 145:93–109
Cabri W, Morra L, Paissoni P, Roletto J (2006) Process for the purification of tacrolimus. WO 2006048145 A1. 1–14
Champaneria MC, Workman AD, Gupta SC (2013) Sushruta: father of plastic surgery. Ann Plast Surg. doi:10.1097/SAP.0b013e31827ae9f5
Chen D, Zhang Q, Zhang Q, Cen P, Xu Z, Liu W (2012) Improvement of FK506 production in Streptomyces tsukubaensis by genetic enhancement of the supply of unusual polyketide extender units via utilization of two distinct site-specific recombination systems. Appl Environ Microbiol 78:5093–5103
Chen D, Zhang L, Pang B, Chen J, Xu Z, Abe I, Liu W (2013) FK506 maturation involves a cytochrome p450 protein-catalyzed four-electron C-9 oxidation in parallel with a C-31 O-methylation. J Bacteriol 195:1931–1939
Choi B-T, Ham Y-B, Yu S-S, Jeong K-I, Kim B-S (2013) Method for refining of high purity of tacrolimus. US8362238 B2. 2:1–8
Fierro F, Barredo JL, Díez B, Gutierrez S, Fernández FJ, Martín JF (1995) The penicillin gene cluster is amplified in tandem repeats linked by conserved hexanucleotide sequences. Proc Natl Acad Sci U S A 92:6200–6204
Garrity GM, Heimbuch BK, Motamedi H, Shafiee a (1993) Genetic relationships among actinomycetes that produce the immunosuppressant macrolides FK506, FK520/FK523 and rapamycin. J Ind Microbiol 12:42–47
Gomez-Escribano JP, Bibb MJ (2011) Engineering Streptomyces coelicolor for heterologous expression of secondary metabolite gene clusters. Microb Biotechnol 4:207–215
Goranovic D, Kosec G, Mrak P, Fujs S, Horvat J, Kuscer E, Kopitar G, Petkovic H (2010) Origin of the allyl group in FK506 biosynthesis. J Biol Chem 285:14292–14300
Goranovič D, Blažič M, Magdevska V, Horvat J, Kuščer E, Polak T, Santos-Aberturas J, Martínez-Castro M, Barreiro C, Mrak P, Kopitar G, Kosec G, Fujs S, Martín JF, Petković H (2012) FK506 biosynthesis is regulated by two positive regulatory elements in Streptomyces tsukubaensis. BMC Microbiol 12:238
Hertweck C (2009) The biosynthetic logic of polyketide diversity. Angew Chem Int Ed Engl 48:4688–4716
Heusler K, Pletscher a (2001) The controversial early history of cyclosporin. Swiss Med Wkly 131:299–302
Huang D, Li S, Xia M, Wen J, Jia X (2013a) Genome-scale metabolic network guided engineering of Streptomyces tsukubaensis for FK506 production improvement. Microb Cell Fact 12:52
Huang D, Xia M, Li S, Wen J, Jia X (2013b) Enhancement of FK506 production by engineering secondary pathways of Streptomyces tsukubaensis and exogenous feeding strategies. J Ind Microbiol Biotechnol 40:1023–1037
Hutchinson CR (1983) Biosynthetic studies of macrolide and polyether antibiotics. Acc Chem Res 16:7–14
Jami M-S, Barreiro C, García-Estrada C, Martín J-F (2010) Proteome analysis of the penicillin producer Penicillium chrysogenum: characterization of protein changes during the industrial strain improvement. Mol Cell proteome MCP 9:1182–1198
Jones AC, Gust B, Kulik A, Heide L, Buttner MJ, Bibb MJ (2013) Phage p1-derived artificial chromosomes facilitate heterologous expression of the FK506 gene cluster. PLoS One 8:e69319
Jung S, Moon S, Lee K, Park Y-J, Yoon S, Yoo YJ (2009) Strain development of Streptomyces sp. for tacrolimus production using sequential adaptation. J Ind Microbiol Biotechnol 36:1467–1471
Jung S, Lee K, Park Y-J, Yoon S, Yoo YJ (2011) Process development for purifying tacrolimus from Streptomyces sp. using adsorption. Biotechnol Bioprocess Eng 16:1208–1213
Keri V, Csorvasi A, Melczer I, Simon A (2006) Method of purifying tacrolimus. US 2006/0142565 A1. 1:1–8
Kim HS, Park YI (2008) Isolation and identification of a novel microorganism producing the immunosuppressant tacrolimus. J Biosci Bioeng 105:418–421
Kim W, Lee JJ, Paik S-G, Hong Y-S (2010) Identification of three positive regulators in the geldanamycin PKS gene cluster of Streptomyces hygroscopicus JCM4427. J Microbiol Biotechnol 20:1484–1490
Kim DH, Ryu JH, Lee KS, Lee BM, Lee MO, Lim S-K, Maeng PJ (2013) Mutational biosynthesis of tacrolimus analogues by fkbO deletion mutant of Streptomyces sp. KCTC 11604BP. Appl Microbiol Biotechnol. doi:10.1007/s00253-013-4716-1
Kino T, Goto T (1993) Discovery of FK-506 and update. Ann N Y Acad Sci 685:13–21
Kino T, Hatanaka H, Hashimoto M, Nishiyama M, Goto T, Okuhara M, Kohsaka M, Aoki H, Imanaka H (1987a) FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics. J Antibiot (Tokyo) 40:1249–1255
Kino T, Hatanaka H, Miyata S, Inamura N, Nishiyama M, Yajima T, Goto T, Okuhara M, Kohsaka M, Aoki H (1987b) FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro. J Antibiot (Tokyo) 40:1256–1265
Konofaos P, Terzis JK (2013) FK506 and nerve regeneration: past, present, and future. J Reconstr Microsurg 29:141–148
Kosec G, Goranovič D, Mrak P, Fujs S, Kuščer E, Horvat J, Kopitar G, Petković H (2012) Novel chemobiosynthetic approach for exclusive production of FK506. Metab Eng 14:39–46
Kumar P, Sharma S, Shukla A, Kumar S, Maurya Rk, Katial V, Mitra A GP (2007) Production of tacrolimus (fk-506) using new streptomyces species. (US20070191415)
Kuscer E, Coates N, Challis I, Gregory M, Wilkinson B, Sheridan R, Petković H (2007) Roles of rapH and rapG in positive regulation of rapamycin biosynthesis in Streptomyces hygroscopicus. J Bacteriol 189:4756–4763
Lechner A, Wilson MC, Ban YH, Hwang J-Y, Yoon YJ, Moore BS (2012) Designed biosynthesis of 36-methyl-FK506 by polyketide precursor pathway engineering. ACS Synth Biol 2:379–383
Lin AN (2010) Innovative use of topical calcineurin inhibitors. Dermatol Clin 28:535–545
Martín J-F, Liras P (2010) Engineering of regulatory cascades and networks controlling antibiotic biosynthesis in Streptomyces. Curr Opin Microbiol 13:263–273
Martínez-Castro M, Solera E, Martín JF, Barreiro C (2009) Efficient pyramidal arrangement of an ordered cosmid library: rapid screening of genes of the tacrolimus-producer Streptomyces sp. ATCC 55098. J Microbiol Methods 78:150–154
Martínez-Castro M, Barreiro C, Romero F, Fernández-Chimeno RI, Martín JF (2011) Streptomyces tacrolimicus sp. nov., a low producer of the immunosuppressant tacrolimus (FK506). Int J Syst Evol Microbiol 61:1084–1088
Martínez-Castro M, Salehi-Najafabadi Z, Romero F, Pérez-Sanchiz R, Fernández-Chimeno RI, Martín JF, Barreiro C (2013) Taxonomy and chemically semi-defined media for the analysis of the tacrolimus producer “Streptomyces tsukubaensis”. Appl Microbiol Biotechnol 97:2139–2152
Medema MH, Alam MT, Breitling R, Takano E (2011) The future of industrial antibiotic production: from random mutagenesis to synthetic biology. Bioeng Bugs 2:230–233
Meier-Kriesche H-U, Li S, Gruessner RWG, Fung JJ, Bustami RT, Barr ML, Leichtman a B (2006) Immunosuppression: evolution in practice and trends, 1994–2004. Am J Transplant 6:1111–1131
Mendes MV, Tunca S, Antón N, Recio E, Sola-Landa A, Aparicio JF, Martín JF (2007) The two-component phoR-phoP system of Streptomyces natalensis: inactivation or deletion of phoP reduces the negative phosphate regulation of pimaricin biosynthesis. Metab Eng 9:217–227
Mishra A, Verma S (2012) Optimization of process parameters for tacrolimus (FK 506) production by new isolate of Streptomyces sp. using response surface methodology. J Biochem Technol 3:419–425
Mo S, Ban Y-H, Park JW, Yoo YJ, Yoon YJ (2009) Enhanced FK506 production in Streptomyces clavuligerus CKD1119 by engineering the supply of methylmalonyl-CoA precursor. J Ind Microbiol Biotechnol 36:1473–1482
Mo S, Kim DH, Lee JH, Park JW, Basnet DB, Ban YH, Yoo YJ, Chen S, Park SR, Choi EA, Kim E, Jin Y-Y, Lee S-K, Park JY, Liu Y, Lee MO, Lee KS, Kim SJ, Kim D, Park BC, Lee S, Kwon HJ, Suh J-W, Moore BS, Lim S-K, Yoon YJ (2011) Biosynthesis of the allylmalonyl-CoA extender unit for the FK506 polyketide synthase proceeds through a dedicated polyketide synthase and facilitates the mutasynthesis of analogues. J Am Chem Soc 133:976–985
Mo S, Yoo YJ, Ban YH, Lee S-K, Kim E, Suh J-W, Yoon YJ (2012) Roles of fkbN in positive regulation and tcs7 in negative regulation of FK506 biosynthesis in Streptomyces sp. strain KCTC 11604BP. Appl Environ Microbiol 78:2249–2255
Mo S, Lee S-K, Jin Y-Y, Oh C-H, Suh J-W (2013) Application of a combined approach involving classical random mutagenesis and metabolic engineering to enhance FK506 production in Streptomyces sp. RM7011. Appl Microbiol Biotechnol 97:3053–3062
Motamedi H, Shafiee A (1998) The biosynthetic gene cluster for the macrolactone ring of the immunosuppressant FK506. Eur J Biochem 256:528–534
Motamedi H, Shafiee a, Cai SJ, Streicher SL, Arison BH, Miller RR (1996) Characterization of methyltransferase and hydroxylase genes involved in the biosynthesis of the immunosuppressants FK506 and FK520. J Bacteriol 178:5243–5248
Motamedi H, Cai SJ, Shafiee A, Elliston KO (1997) Structural organization of a multifunctional polyketide synthase involved in the biosynthesis of the macrolide immunosuppressant FK506. Eur J Biochem 244:74–80
Muramatsu H, Nagai K (2013) Streptomyces tsukubensis sp. nov., a producer of the immunosuppressant tacrolimus. J Antibiot (Tokyo) 66:251–254
Muramatsu H, Mokhtar SI, Katsuoka M, Ezaki M (2005) Phylogenetic analysis of immunosuppressant FK506-producing streptomycete strains. Actinomycetologica 19:33–39
Park JW, Mo S-J, Park SR, Ban Y-H, Yoo YJ, Yoon YJ (2009) Liquid chromatography–mass spectrometry characterization of FK506 biosynthetic intermediates in Streptomyces clavuligerus KCTC 10561BP. Anal Biochem 393:1–7
Patel JK, Kobashigawa J a (2004) Cardiac transplant experience with cyclosporine. Transplant Proc 36:323S–330S
Patel P, Patel H, Panchal S, Mehta T (2012) Formulation strategies for drug delivery of tacrolimus: an overview. Int J Pharm Investig 2:169–175
Rath T (2013) Tacrolimus in transplant rejection. Expert Opin Pharmacother 14:115–122
Ritacco FV, Graziani EI, Summers MY, Zabriskie TM, Yu K, Bernan VS, Carter GT, Greenstein M (2005) Production of novel rapamycin analogs by precursor-directed biosynthesis. Appl Environ Microbiol 71:1971–1976
Rodríguez-García A, Barreiro C, Santos-Beneit F, Sola-Landa A, Martín JF (2007) Genome-wide transcriptomic and proteomic analysis of the primary response to phosphate limitation in Streptomyces coelicolor M145 and in a DeltaphoP mutant. Proteomics 7:2410–2429
Savic M, Bratic I, Vasiljevic B (2007) Streptomyces durmitorensis sp. nov., a producer of an FK506-like immunosuppressant. Int J Syst Evol Microbiol 57:2119–2124
Shafiee A, Motamedi H, Chen T (1994) Enzymology of FK-506 biosynthesis. Purification and characterization of 31-O-desmethylFK-506 O: methyltransferase from Streptomyces sp. MA6858. Eur J Biochem 225:755–764
Shapiro R, Young JB, Milford EL, Trotter JF, Bustami RT, Leichtman AB (2005) Immunosuppression: evolution in practice and trends, 1993–2003. Am J Transplant 5:874–886
Sierra-Paredes G, Sierra-Marcuño G (2008) Ascomycin and FK506: pharmacology and therapeutic potential as anticonvulsants and neuroprotectants. CNS Neurosci Ther 14:36–46
Sigmund JM, Clark DC, Rainey FA, Anderson AS (2003) Detection of eubacterial 3-hydroxy-3-methylglutaryl coenzyme a reductases from natural populations of actinomycetes. Microb Ecol 46:106–112
Singh BP, Behera BK (2009) Regulation of tacrolimus production by altering primary source of carbons and amino acids. Lett Appl Microbiol 49:254–259
Stähelin HF (1996) The history of cyclosporin A (Sandimmune) revisited: another point of view. Experientia 52:5–13
Turło J, Gajzlerska W, Klimaszewska M, Król M, Dawidowski M, Gutkowska B (2012) Enhancement of tacrolimus productivity in Streptomyces tsukubaensis by the use of novel precursors for biosynthesis. Enzyme Microb Technol 51:388–395
Wallemacq PE, Reding R (1993) FK506 (tacrolimus), a novel immunosuppressant in organ transplantation: clinical, biomedical, and analytical aspects. Clin Chem 39:2219–2228
Wu K, Chung L, Revill WP, Katz L, Reeves CD (2000) The FK520 gene cluster of Streptomyces hygroscopicus var. ascomyceticus (ATCC 14891) contains genes for biosynthesis of unusual polyketide extender units. Gene 251:81–90
Xia M, Huang D, Li S, Wen J, Jia X, Chen Y (2013) Enhanced FK506 production in Streptomyces tsukubaensis by rational feeding strategies based on comparative metabolic profiling analysis. Biotechnol Bioeng 110:2717–2730
Yoon YJ, Choi CY (1997) Nutrient effects on FK-506, a new immunosuppressant, production by Streptomyces sp. in a defined medium. J Ferment Bioeng 83:599–603
Acknowledgments
We acknowledge Juan F. Martín for his kind introduction to the tacrolimus study by Streptomyces species; H. Petkovic for his advice about immunosuppressant-producing species and C. Prieto, S. Albillos and A. Sola-Landa for their support on scientific concerns. We thank A. Mulero-Fernández for her excellent technical assistance. Special thanks to the anonymous reader that day by day improves our work.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Barreiro, C., Martínez-Castro, M. Trends in the biosynthesis and production of the immunosuppressant tacrolimus (FK506). Appl Microbiol Biotechnol 98, 497–507 (2014). https://doi.org/10.1007/s00253-013-5362-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00253-013-5362-3